Paluray, Remegio S.
HRN: 22-17-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2022
CEFTRIAXONE 1G (VIAL)
11/15/2022
11/17/2022
IVT
2g
Od X 3 Days More
Alcoholic Liver Disease
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes